ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ERAS

Rosen Law Firm is urging investors who purchased Erasca, Inc. (ERAS) stock between January 14, 2025 and April 26, 2026 to join a securities class action lawsuit before the August 10, 2026 lead plaintiff deadline. The lawsuit alleges that Erasca and its executives made false and misleading statements about its oncology drug candidate ERAS-0015, including improper comparisons to a competing drug that lacked reasonable basis and exposed the company to patent disputes.